Vaccine Production, Ordering, and Distribution
Seasonal Influenza Vaccines for the 2011-2012
Season
| Manufacturer |
Trade Name |
How Supplied |
Mercury
Content
(mcg
Hg/0.5
mL dose) |
Age Group |
CSL Biotherapies
(Distributed by Merck Vaccines) |
Afluria |
0.5 mL (single-dose
syringe) |
0 |
9 years & older |
| GlaxoSmithKline (GSK) |
Fluarix |
0.5 mL
(single-dose syringe) |
0 |
36 months & older |
ID
Biomedical Corporation of Quebec
(Distributed by GlaxoSmithKline) |
FluLaval |
5.0 mL (10-dose vial) |
25 |
18 years & older |
| MedImmune |
FluMist |
0.2 mL
(single-use sprayer) |
0 |
2 through 49 years |
| Novartis Vaccines |
Fluvirin |
0.5 mL (single-dose syringe) |
<1 |
4 years and older |
| 5.0 mL (10-dose vial) |
25 |
| Agiflu |
0.5 mL (single-dose syringe) |
0 |
18 years & older |
| sanofi pasteur |
Fluzone |
0.25 mL
(single-dose syringe) |
0 |
6 through 35
months |
| 5.0 mL
(multi-dose vial) |
12.5 |
6 through 35
months |
| 0.5 mL
(single-dose syringe) |
0 |
36 months & older |
| 0.5 mL
(single-dose vial) |
0 |
36 months & older |
| 5.0 mL
(multi-dose vial) |
25 |
6 months & older |
| Fluzone High-Dose |
0.5 mL
(single-dose syringe) |
0 |
65 years & older |
| Fluzone
Intradermal |
0.1 mL
(single-dose microinjection
system) |
0 |
18 through 64
years |
Seasonal Influenza Vaccine Ordering
Most providers order influenza vaccine for the coming vaccination season in the
winter and spring of the preceding year. Depending on many factors, orders can
be placed direct with the manufacturer, with a distributor, the state's VFC
program, or a group purchasing arrangement.
Interested in Learning More About Influenza
Vaccine Production?
Read a report from the Health Industry Distributors Association, a non-profit trade
association of medical products distributors who service healthcare providers,
that explains the process that determines when and how vaccine reaches doctors,
hospitals, nursing homes, and others.
Understanding the Dynamics of Influenza Vaccine Supply and Demand -- Five
Issue Briefs. This series of briefs were prepared for the Assistant Secretary
for Planning and Evaluation of the Department of Health and Human Services in
October 2005.
Overview -- Summary and Assessment: roles and responsibilities of the
influenza vaccine stakeholders.
Vaccine Economics: characteristics of the influenza vaccine market, industry
regulatory requirements for vaccine productions, and factors affecting the
profitability of vaccine production.
Who Buys It and Who Sells It: the vaccine supply chain and potential means
for facilitating vaccine purchase and distribution.
Vaccine Manufacturing: the unique characteristics of the influenza vaccine,
the structure of the industry, decisions about the amount of vaccine produced
each year, investments in new technologies, and other factors.
The Chicken and the Egg: factors that impact the demand for vaccine and how
they can affect supply. |
|
HCP Home
